A new article in the Journal of the American Medical Association said the FDA will implement AI into multiple processes.

The company announced that the US FDA has expanded the approved use of its oral antiviral drug Mavyret, developed in ...

Ambient listening software is part of a buzzy new technology being marketed as AI “scribes,” or assistants, to help doctors ...

Insmed Incorporated (NASDAQ:INSM) is a New Jersey-based biopharmaceutical company that develops and markets therapies to ...

Sonu, an AI-enabled wearable device, is now approved for use in pediatric patients aged 12 years and older for the relief of moderate to severe nasal ...

There are subtle but significant differences in the morphology and biochemistry of the eye between men and women. These differences may affect disease susceptibility, symptoms and progression, ...

Elsa” is the FDA’s new anthropomorphized AI tool which, the FDA hopes, will speed up clearances, licenses, and approvals ...

In late May 2025, a New York Times article detailed a supposed combined effort between the U.S. federal government and the ...